Market Tracker

04/17 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
8.26 +0.07 / +0.85%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.26 0.00 / 0.00%
 
Volume: 1.3K

Today’s Trading

Previous close8.19
Today’s open8.14
Day’s range8.02 - 8.48
Volume253,358
Average volume (3 months)578,188
Market cap$356.1M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+62.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.12

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc-0.11-3.90%
SNTASynta Pharmaceutical...-0.08-1.98%
RPRXRepros Therapeutics ...+0.28+1.78%
SNSSSunesis Pharmaceutic...-0.02-0.39%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateJune 5, 2014
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Founder
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts